pubmed-article:14760324 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0021368 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0948089 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0016017 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0206461 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0288672 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0427579 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0441509 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:14760324 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:14760324 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:14760324 | pubmed:dateCreated | 2004-2-4 | lld:pubmed |
pubmed-article:14760324 | pubmed:abstractText | In acute coronary syndromes, the inflammation and the coagulation systems are activated, implying an impaired outcome. In addition to platelet inhibition, recent evidence suggests that the glycoprotein IIb/IIIa receptor inhibitor abciximab attenuates inflammation and coagulation activity. | lld:pubmed |
pubmed-article:14760324 | pubmed:language | eng | lld:pubmed |
pubmed-article:14760324 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14760324 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14760324 | pubmed:month | Feb | lld:pubmed |
pubmed-article:14760324 | pubmed:issn | 1097-6744 | lld:pubmed |
pubmed-article:14760324 | pubmed:author | pubmed-author:SimoonsMaarte... | lld:pubmed |
pubmed-article:14760324 | pubmed:author | pubmed-author:WallentinLars... | lld:pubmed |
pubmed-article:14760324 | pubmed:author | pubmed-author:SiegbahnAgnet... | lld:pubmed |
pubmed-article:14760324 | pubmed:author | pubmed-author:ArmstrongPaul... | lld:pubmed |
pubmed-article:14760324 | pubmed:author | pubmed-author:JamesStefan... | lld:pubmed |
pubmed-article:14760324 | pubmed:author | pubmed-author:BarnathanElli... | lld:pubmed |
pubmed-article:14760324 | pubmed:author | pubmed-author:CaliffRobertR | lld:pubmed |
pubmed-article:14760324 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:14760324 | pubmed:volume | 147 | lld:pubmed |
pubmed-article:14760324 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14760324 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14760324 | pubmed:pagination | 267-74 | lld:pubmed |
pubmed-article:14760324 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:meshHeading | pubmed-meshheading:14760324... | lld:pubmed |
pubmed-article:14760324 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14760324 | pubmed:articleTitle | Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy. | lld:pubmed |
pubmed-article:14760324 | pubmed:affiliation | Department of Medical Sciences, Cardiology, Thoraxcenter, Academic Hospital, Uppsala, Sweden. stefan.james@akademiska.se | lld:pubmed |
pubmed-article:14760324 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14760324 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:14760324 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:14760324 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:14760324 | pubmed:publicationType | Multicenter Study | lld:pubmed |